BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management
28 août 2019 07h45 HE
|
BioDelivery Sciences International, Inc.
RALEIGH, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic...
SPR Therapeutics’ SPRINT Peripheral Nerve Stimulation System Significantly Reduces Opioid Use in Patients with Low Back Pain, Interim Data Show
21 août 2019 08h30 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Ohio and KISSIMMEE, Florida, Aug. 21, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, presented interim results today on the...
Adynxx Reports Second Quarter 2019 Financial Results
14 août 2019 07h00 HE
|
Adynxx, Inc.
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations
08 août 2019 16h05 HE
|
BioDelivery Sciences International, Inc.
BELBUCA® Net Sales Increased 147% versus Prior Year to All-Time High of $24.1 MillionRaises Full-Year BELBUCA Net Sales Expectations to $90 - $93 MillionRaises Full-Year Total Company Net Sales...
Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market
22 juil. 2019 06h00 HE
|
Adynxx, Inc.
SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and...
Bloomberg Philanthropies Selects Pennsylvania Hospitals for Cutting-edge Opioid Learning and Action Collaborative
09 juil. 2019 11h18 HE
|
The Hospital and Healthsystem Association of Pennsylvania
Harrisburg, PA, July 09, 2019 (GLOBE NEWSWIRE) -- The opioid crisis has taken a devastating toll on Pennsylvania. During the three-year period from 2015 to 2017, there were 13,408 drug-related...
BioDelivery Sciences Expands Upon Report from Pain Management Task Force
24 juin 2019 08h00 HE
|
BioDelivery Sciences International, Inc.
Company’s Activities Support Buprenorphine Recommendations Including: Primary Use of Buprenorphine in Chronic Pain when Clinically IndicatedHaving Payers Provide Coverage and Reimbursement for...
BioDelivery Sciences Strengthens Financial Position with Debt Refinancing
28 mai 2019 16h10 HE
|
BioDelivery Sciences International, Inc.
New Agreement is Cash Flow Accretive, Lowers Cost of Capital and Extends Debt Maturity Reduces Annual Interest Costs by Approximately $1.5 million Increases Flexibility to Continue Growth Trajectory...
Progressive Care Inc. Issues 1st Quarter 2019 Quarterly Report Conference Call Highlights
16 mai 2019 08h00 HE
|
Progressive Care, Inc.
MIAMI, May 16, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today issued 1st Quarter 2019 Quarterly Report Conference Call...
Veritas Announces the Completion of Clinical Trial on their Cannabis Product for Treatment of Acute Pain
15 mai 2019 08h00 HE
|
Veritas Pharma Inc.
SAN JUAN, Puerto Rico, May 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), is...